Joseph Shulman

All filings by Joseph Shulman on record concern Rhythm Pharmaceuticals, Inc., in the capacity of senior executive. In total, 31 filings cover trades dated from 11 February 2022 to 13 August 2026.

The open-market record consists of 6 sales worth €1.9M, with no purchase. Outside the open market, there are 1 share grant and 24 option exercises. Since January 2026: no purchases and 1 sale on the market.

The newest entry dates from 17 August 2026: an option exercise of €12k, in Rhythm Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.